In addition, univariate and multivariate Cox analyses suggested that TP53 mutation is an independent risk factor for the prognosis of HCC, which may provide a novel biomarker for the prediction of disease status and prognosis of HCC patients, which is extremely vital for appropriate monitoring and selection of treatment methods. The gene discussed is TP53; the disease is hepatocellular carcinoma.